Anti-CTLA-4 human scFv antibodies prevent T-cell activation in transplantation.
Pistillo
M P
MP
Immunogenetics Laboratory, National Cancer Research Institute and Department of Oncology, Biology, and Genetics, c/o CBA, Genova, Italy.
Tazzari
P L
PL
Stirpe
F
F
Bolognesi
A
A
Polito
L
L
Capanni
P
P
Pioli
C
C
Gatta
L
L
Ubaldi
V
V
Doria
G
G
Conte
R
R
Ferrara
G B
GB
D000069594:Abatacept; D000906:Antibodies / Q000276:immunology*; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000276:immunology*; D060908:CTLA-4 Antigen; D006801:Humans; D018796:Immunoconjugates; D007135:Immunoglobulin Variable Region / Q000276:immunology*; D000922:Immunotoxins / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000906:Antibodies; D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D007135:Immunoglobulin Variable Region; D000922:Immunotoxins; D000069594:Abatacept